Enrolling by Invitation
Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL
NCT06468943
- Conditions
- Effects of Chemotherapy, Safety Issues
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Nanjing, China